
    
      A prospective, single-blind, randomized, multicenter, two arm study. The objective of this
      study is to show similar (non-inferior) safety and effectiveness between CYPHER® ELITE™ and
      CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems in a prospective, multi-center,
      randomized clinical study for the treatment of de novo native coronary lesions.
    
  